Related references
Note: Only part of the references are listed.Atherothrombotic factors and atherosclerotic cardiovascular events: the multi-ethnic study of atherosclerosis
Andrew P. DeFilippis et al.
EUROPEAN HEART JOURNAL (2022)
Intensive low-density lipoprotein cholesterol lowering improves fibrin clot properties: Association with lipoproteins and C-reactive protein
Jakub Siudut et al.
VASCULAR PHARMACOLOGY (2022)
Practical guidance for P2Y12 inhibitors in acute myocardial infarction undergoing percutaneous coronary intervention
Seung Hun Lee et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2021)
Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation
Agata Hanna Bryk-Wiazania et al.
CARDIOVASCULAR DIABETOLOGY (2021)
Association Between Thrombogenicity Indices and Coronary Microvascular Dysfunction in Patients With Acute Myocardial Infarction
Min Gyu Kang et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2021)
Ethnic Difference of Thrombogenicity in Patients with Cardiovascular Disease: a Pandora Box to Explain Prognostic Differences
Hyun Kuk Kim et al.
KOREAN CIRCULATION JOURNAL (2021)
Comparison of three common whole blood platelet function tests for in vitro P2Y12 induced platelet inhibition
Joao D. Dias et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
The Impact of platelet-fibrin clot strength on occurrence and clinical outcomes of peripheral artery disease in patients with significant coronary artery disease
Jae Seok Bae et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
2018 ESC/EACTS Guidelines on myocardial revascularization
Franz-Josef Neumann et al.
EUROPEAN HEART JOURNAL (2019)
Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation
Nikolaos Spinthakis et al.
EUROPACE (2019)
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention
Dirk Sibbing et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2019)
Impaired Spontaneous/Endogenous Fibrinolytic Status as New Cardiovascular Risk Factor? JACC Review Topic of the Week
Diana A. Gorog et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Impaired endogenous fibrinolysis in ST-segment elevationmyocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study
Mohamed Farag et al.
EUROPEAN HEART JOURNAL (2019)
Standardized End Point Definitions for Coronary Intervention Trials The Academic Research Consortium-2 Consensus Document
Hector M. Garcia-Garcia et al.
CIRCULATION (2018)
Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy
Wael Sumaya et al.
EUROPEAN HEART JOURNAL (2018)
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
J. W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Von Willebrand Factor and Cardiovascular Disease: From a Biochemical Marker to an Attractive Therapeutic Target
Felice Gragnano et al.
CURRENT VASCULAR PHARMACOLOGY (2017)
Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk
Katherine Kearney et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation
Yee Cheng Lau et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2016)
Endogenous Fibrinolysis
Osita N. Okafor et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
Marc P. Bonaca et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The vulnerable blood Coagulation and clot structure in diabetes mellitus
K. Hess
HAMOSTASEOLOGIE (2015)
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
Laura Mauri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Thrombin-induced platelet-fibrin clot strength: Relation to high on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes
Young-Hoon Jeong et al.
THROMBOSIS AND HAEMOSTASIS (2014)
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
Ph. Gabriel Steg et al.
EUROPEAN HEART JOURNAL (2012)
Fibrin Clot Structure and Function A Role in the Pathophysiology of Arterial and Venous Thromboembolic Diseases
Anetta Undas et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
Glenn N. Levine et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Adenosine diphosphate-induced platelet-fibrin clot strength: A new thrombelastographic indicator of long-term poststenting ischemic events
Paul A. Gurbel et al.
AMERICAN HEART JOURNAL (2010)
Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis
Deepak L. Bhatt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Prognostic Value of Plasma Fibrinolysis Activation Markers in Cardiovascular Disease
Diana A. Gorog
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
A 2-Step Mechanism of Arterial Thrombus Formation Induced by Human Atherosclerotic Plaques
Armin J. Reininger et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Impaired Endogenous Thrombolysis in Acute Coronary Syndrome Patients Predicts Cardiovascular Death and Nonfatal Myocardial Infarction
Smriti Saraf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: Results of the Thrombotic RIsk Progression (TRIP) Study
Udaya S. Tantry et al.
PLATELETS (2010)
Relation of Clinically Defined Spontaneous Reperfusion to Outcome in ST-Elevation Myocardial Infarction
Paul Fefer et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
The link between heightened thrombogenicity and inflammation: Pre-procedure characterization of the patient at high risk for recurrent events after stenting
Paul A. Gurbel et al.
PLATELETS (2009)
Platelet reactivity in patients and recurrent events post-stenting - Results of the PREPARE POST-STENTlNG study
PA Gurbel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis - A pathological thrombectomy study in primary percutaneous coronary intervention
SZH Rittersma et al.
CIRCULATION (2005)
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
